Despite the capacity of chaperones and other homeostatic components to restore folding equilibrium, cells appear poorly adapted for chronic oxidative stress that increases in cancer and in metabolic and neurodegenerative diseases. Modulation of endogenous cellular defense mechanisms represents an innovative approach to therapeutic intervention in diseases causing chronic tissue damage, such as in neurodegeneration. This article introduces the concept of hormesis and its applications to the field of neuroprotection. It is argued that the hormetic dose response provides the central underpinning of neuroprotective responses, providing a framework for explaining the common quantitative features of their dose–response relationships, their mechanistic foundations, and their relationship to the concept of biological plasticity, as well as providing a key insight for improving the accuracy of the therapeutic dose of pharmaceutical agents within the highly heterogeneous human population. This article describes in mechanistic detail how hormetic dose responses are mediated for endogenous cellular defense pathways, including sirtuin and Nrf2 and related pathways that integrate adaptive stress responses in the prevention of neurodegenerative diseases. Particular attention is given to the emerging role of nitric oxide, carbon monoxide, and hydrogen sulfide gases in hormetic-based neuroprotection and their relationship to membrane radical dynamics and mitochondrial redox signaling. Antioxid. Redox Signal. 13, 1763–1811.
AbramowitzJ, DaiC, HirschiKK, DmitievaRI, DorisPA, LiuL, AllenJC. Ouabain- and marinobufagenin-induced proliferation of human umbilical vein smooth muscle cells and a rat vascular smooth muscle cell lines, A7r5. Circulation, 108:3048–3053. 2003.
2.
AfonsoV, ChampyR, MitrovicD, CollinP, LomriA. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine, 74:324–329. 2007.
3.
AhnBH, KimHS, SongS, LeeIH, LiuJ, VassilopoulosA, DengCX, FinkelT. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc Natl Acad Sci USA, 105:14447–14452. 2008.
4.
AkhtarMW, RaingoJ, NelsonED, MontgomeryRL, OlsonEN, KavalaliET, MonteggiaLM. Histone deacetylases 1 and 2 form a developmental switch that controls excitatory synapse maturation and function. J Neurosci, 29:8288–8297. 2009.
5.
AlamJ, CookJL. How many transcription factors does it take to turn on the heme oxygenase-1 gene?Am J Respir Cell Mol Biol, 36:166–174. 2007.
6.
AlbaniD, PolitoL, BatelliS, De MauroS, FracassoC, MartelliG, ColomboL, ManzoniC, SalmonaM, CacciaS, NegroA, ForloniG. The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1–42) peptide. J Neurochem, 110:1445–1456. 2009.
7.
AlbertoR, MotterliniR. Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes. Dalton Trans, 7:1651–1660. 2007.
8.
AlievG, PalaciosHH, LipsittAE, FischbachK, LambBT, ObrenovichME, MoralesL, GasimovE, BraginV. Nitric oxide as an initiator of brain lesions during the development of Alzheimer disease. Neurotox Res, 16:293–305. 2009.
9.
AllisonAC, CacabelosR, LombardiVR, AlvarezXA, VigoC. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry, 25:1341–1357. 2001.
10.
AltmeyerPJ, MatthesU, PawlakF, HoffmannK, FroschPJ, RuppertP, WassilewSW, HornT, KreyselHW, LutzG. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol, 30:977–981. 1994.
11.
AmijeeH, MadineJ, MiddletonDA, DoigAJ. Inhibitors of protein aggregation and toxicity. Biochem Soc Trans, 37:692–696. 2009.
12.
AnandP, NairHB, SungB, KunnumakkaraAB, YadavVR, TekmalRR, AggarwalBB. Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol, 79:330–338. 2010.
13.
AnckarJ, SistonenL. Heat shock factor 1 as a coordinator of stress and developmental pathways. Adv Exp Med Biol, 594:78–88. 2007.
14.
AndersonRM, BargerJL, EdwardsMG, BraunKH, O'ConnorCE, ProllaTA, WeindruchR. Dynamic regulation of PGC-1α localization and turnover implicates mitochondrial adaptation in caloric restriction and the stress response. Aging Cell, 7:101–111. 2008.
15.
ArakiT, SasakiY, MilbrandtJ. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science, 305:1010–1013. 2004.
16.
ArgaudL, PrigentAF, ChalabreysseL, LoufouatJ, LagardeM, OvizeM. Ceramide in the antiapoptotic effect of ischemic preconditioning. Am J Physiol Heart Circ Physiol, 286:H246–H251. 2004.
17.
ArumugamTV, PhillipsTM, ChengA, MorrellCH, MattsonMP, WanR. Age and energy intake interact to modify cell stress pathways and stroke outcome. Ann Neurol, 67:41–52. 2010.
18.
AvernaM, StifaneseR, De TullioR, BeccariaF, SalaminoF, PontremoliS, MelloniE. Calpain-mediated activation of NO synthase in human neuroblastoma SK-N-BE cells. J Neurochem, 110:412–421. 2009.
19.
BalanV, MillerGS, KaplunL, BalanK, ChongZZ, LiF, KaplunA, VanBerkumMF, ArkingR, FreemanDC, MaieseK, TzivionG. Life span extension and neuronal cell protection by Drosophila nicotinamidase. J Biol Chem, 283:27810–27819. 2008.
BarrettRM, WoodMA. Beyond transcription factors: the role of chromatin modifying enzymes in regulating transcription required for memory. Learn Mem, 15:460–467. 2008.
23.
BaskarR, SparatoreA, Del SoldatoP, MoorePK. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation. Eur J Pharmacol, 594:1–8. 2008.
24.
BatulanZ, ShinderGA, MinottiS, HeBP, DoroudchiMM, NalbantogluJ, StrongMJ, DurhamHD. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J Neurosci, 23:5789–5798. 2003.
25.
BauerI, PannenBH. Bench-to-bedside review: carbon monoxide—from mitochondrial poisoning to therapeutic use. Crit Care, 13:220. 2009.
26.
BeherD, WuJ, CumineS, KimKW, LuSC, AtanganL, WangM. Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des, 74:619–624. 2009.
27.
BelliaF, CalabreseV, GuarinoF, CavallaroM, CorneliusC, De PintoV, RizzarelliE. Carnosinase levels in aging brain: redox state induction and cellular stress response. Antioxid Redox Signal, 11:2759–2775. 2009.
28.
BenharM, ForresterMT, StamlerJS. Protein denitrosylation: enzymatic mechanisms and cellular functions. Nat Rev Mol Cell Biol, 10:721–732. 2009.
29.
BensassonRV, ZoeteV, Dinkova-KostovaAT, TalalayP. Two-step mechanism of induction of the gene expression of a prototypic cancer-protective enzyme by diphenols. Chem Res Toxicol, 21:805–812. 2008.
30.
BentonCR, WrightDC, BonenA. PGC-1alpha-mediated regulation of gene expression and metabolism: implications for nutrition and exercise prescriptions. Appl Physiol Nutr Metab, 33:843–862. 2008.
31.
BerenblumI. The modifying influence of dichloroethyl sulphide on the induction of tumours in mice by tar. J Pathol Bacteriol, 32:425–434. 1929.
32.
BezprozvannyI, MattsonMP. Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci, 31:454–463. 2008.
BishopNA, GuarenteL. Genetic links between diet and lifespan: shared mechanisms from yeast to humans. Nat Rev Genet, 8:835–844. 2007.
35.
BishopA, GoochR, EguchiA, JeffreyS, SmallwoodL, AndersonJ, EstevezAG. Mitigation of peroxynitrite-mediated nitric oxide (NO) toxicity as a mechanism of induced adaptive NO resistance in the CNS. J Neurochem, 109:74–84. 2009.
36.
BlackstoneE, MorrisonM, RothMB. H2S induces a suspended animation-like state in mice. Science, 308:518. 2005.
37.
BlancEM, KellyJF, MarkRJ, WaegG, MattsonMP. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on G alpha(q/11)J Neurochem, 69:570–580. 1997.
BonifatiV, RizzuP, van BarenMJ, SchaapO, BreedveldGJ, KriegerE, DekkerMC, SquitieriF, IbanezP, JoosseM, van DongenJW, VanacoreN, van SwietenJC, BriceA, MecoG, van DuijnCM, OostraBA, HeutinkP. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299:256–259. 2003.
40.
BorakJ, SirianniG. Hormesis: implications for cancer risk assessment. Dose Response, 3:443–451. 2005.
41.
BorehamDR, DollingJ-A, SomersC, QuinnJ, MitchelREJ. The adaptive response and protection against heritable mutations and fetal malformation. Dose Response, 4:317–326. 2006.
42.
BrignullHR, MorleyJF, MorimotoRI. The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Adv Exp Med Biol, 594:167–189. 2007.
43.
BroadleySA, HartlFU. The role of molecular chaperones in human misfolding diseases. FEBS Lett, 583:2647–2653. 2009.
44.
BrownIR. Heat shock proteins and protection of the nervous system. Ann NY Acad Sci, 1113:147–158. 2007.
45.
BruceAJ, BolingW, KindyMS, PeschonJ, KraemerPJ, CarpenterMK, HoltsbergFW, MattsonMP. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat Med, 2:788–794. 1996.
46.
Bruce-KellerAJ, BegleyJG, FuW, ButterfieldDA, BredesenDE, HutchinsJB, HensleyK, MattsonMP. Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. J Neurochem, 70:31–39. 1998.
47.
Bruce-KellerAJ, GeddesJW, KnappPE, McFallRW, KellerJN, HoltsbergFW, ParthasarathyS, SteinerSM, MattsonMP. Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. J Neuroimmunol, 93:53–71. 1999.
48.
BurtonNC, KenslerTW, GuilarteTR. In vivo modulation of the Parkinsonian phenotype by Nrf2. Neurotoxicology, 27:1094–1100. 2006.
49.
CalabreseEJ. Evidence that hormesis represents an “overcompensation” response to a disruption in homeostasis. Ecotoxicol Environ Saf, 42:135–137. 1999.
50.
CalabreseEJ, BaldwinLA. Chemical hormesis: its historical foundations as a biological hypothesis. Hum Exp Toxicol, 19:2–31. 2000.
51.
CalabreseEJ, BaldwinLA. The marginalization of hormesis. Hum Exper Toxicol, 19:32–40. 2000.
52.
CalabreseEJ, BaldwinLA. Radiation hormesis: its historical foundations as a biological hypothesis. Hum Exp Toxicol, 19:41–75. 2000.
53.
CalabreseEJ, BaldwinLA. Radiation hormesis: the demise of a legitimate hypothesis. Hum Exp Toxicol, 19:76–84. 2000.
54.
CalabreseEJ, BaldwinLA. Tales of two similar hypotheses: the rise and fall of chemical and radiation hormeis. Hum Exp Toxicol, 19:85–97. 2000.
55.
CalabreseEJ, BaldwinLA. The frequency of U-shaped dose-responses in the toxicological literature. Toxicol Sci, 62:330–338. 2001.
56.
CalabreseEJ, BaldwinLA. Hormesis: U-shaped dose-response and their centrality in toxicology. Trends Pharmacol Sci, 22:285–291. 2001.
57.
CalabreseEJ, BaldwinLA. U-shaped dose responses in biology, toxicology, and public health. Ann Rev Public Health, 22:15–33. 2001.
58.
CalabreseEJ. Overcompensation stimulation: a mechanism for hormetic effects. Crit Rev Toxicol, 31:425–470. 2001.
59.
CalabreseEJ, BaldwinLA. Hormesis and high risk groups. Regul Toxiclo Pharmacol, 35:14–428. 2002.
60.
CalabreseEJ, BaldwinLA. The hormetic dose response model is more common than the threshold model in toxicology. Toxicol Sci, 71:246–250. 2003.
61.
CalabreseEJ, BaldwinLA. Inorganics and hormesis. Crit Rev Toxicol, 33:215–304. 2003.
62.
CalabreseEJ, BaldwinLA. Chemotherapeutics and hormesis. Crit Rev Toxicol, 33:305–354. 2003.
63.
CalabreseEJ, BaldwinLA. Peptides and hormesis. Crit Rev Toxicol, 33:355–406. 2003.
64.
CalabreseEJ, BaldwinLA. Ethanol and hormesis. Crit Rev Toxicol, 33:407–424. 2003.
65.
CalabreseEJ. Historical blunders: how toxicology got the dose-response relationship half right. Cell Mol Biol, 51:643–654. 2005.
66.
CalabreseEJ. Hormetic dose-response relationships in immunology: occurrence, quantitative features of the dose response, mechanistic foundations, and clinical foundations. Crit Rev Toxicol, 35:89–295. 2005.
67.
CalabreseEJ. Cancer biology and hormesis: Human tumore cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol, 35:463–582. 2005.
68.
CalabreseEJ, BlainR. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol, 202:289–301. 2005.
69.
CalabreseEJ, StaudenmayerJW, StanekEJ. Drug development and hormesis: changing conceptual understanding of the dose response creates new challenges and opportunities for more effective drugs. Curr Opin Drug Discov Dev, 9:117–123. 2006.
70.
CalabreseEJ, StaudenmayerJW, StanekEJ, HoffmannGR. Hormesis outperforms threshold model in NCI anti-tumor drug screening data. Toxicol Sci, 94:368–378. 2006.
71.
CalabreseEJ, StaudenmayerJW, Stanek IIIEJ, HoffmannGR. Hormesis and high throughput studies: crump's analysis lacks credibility. Toxicol Sci, 98:602–603. 2007
CalabreseEJ. Alzheimer's disease drugs: An application of the hormetic dose-response model. Crit Rev Toxicol, 38:419–452. 2008.
78.
CalabreseEJ. Stress biology and hormesis: the Yerkes-Dodson law in psychology—a special case of the hormesis dose response. Crit Rev Toxicol, 38:453–462. 2008.
79.
CalabreseEJ. Astrocytes: Adaptive responses to low doses of neurotoxins. Crit Rev Toxicol, 38:463–472. 2008.
CalabreseEJ. An assessment of anxiolytic drug screening tests: Hormetic dose responses predominate. Crit Rev Toxicol, 38:489–542. 2008.
82.
CalabreseEJ. Modulation of the epileptic seizure threshold: implications of biphasic dose responses. Crit Rev Toxicol, 38:543–556. 2008.
83.
CalabreseEJ. Drug therapies for stroke and traumatic brain injury often display U-shaped dose responses: occurrence, mechanisms, and clinical implications. Crit Rev Toxicol, 38:557–577. 2008.
84.
CalabreseEJ. Pain and U-shaped dose responses: occurrence, mechanisms, and clinical implications. Crit Rev Toxicol, 38:579–590. 2008.
CalabreseEJ. Addiction and dose response: the psychomotor stimulant theory of addiction reveals that hormetic dose responses are dominant. Crit Rev Toxicol, 38:599–618. 2008.
87.
CalabreseEJ. Hormesis: why it is important to toxicology and toxicologists. Environ Toxicol Chem, 27:1451–1474. 2008.
88.
CalabreseEJ. Hormesis and medicine. Brit J Clin Pharm, 66:594–617. 2008.
89.
CalabreseEJ. Hormesis. Encyclopedia of Quantitative Risk Assessment and Analysis. MelnickE, EverittB. Chichester, United Kingdom: John Wiley & Sons Ltd., 838–844. 2008.
90.
CalabreseEJ, Stanek IIIEJ, NascarellaMA, HoffmannGR. Hormesis predicts low-dose responses better than threshold models. Int J Toxicol, 27:369–378. 2008.
91.
CalabreseEJ. The road to linearity: Shy linearity at low doses became the basis for carcinogen risk assessment. Arch Toxicol, 83:203–225. 2009.
92.
CalabreseEJ. Getting the dose-response wrong: why hormesis became marginalized and the threshold model accepted. Arch Toxicol, 83:227–247. 2009.
93.
CalabreseEJ, BlainRB. Hormesis and plant biology. Environ Poll, 157:42–48. 2009.
94.
CalabreseEJ, RicciPF. Hormesis in environmental health: How hormesis will change the risk assessment process. Encyclopedia of Environmental Health. NriaguJO. Elsevier, 2010(In press).
95.
CalabreseV, Giuffrida StellaAM, ButterfieldDA, ScapagniniG. Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid Redox Signal, 6:895–913. 2004.
96.
CalabreseV, ButterfieldDA, ScapagniniG, StellaAM, MainesMD. Redox regulation of heat shock protein expression by signaling involving nitric oxide and carbon monoxide: relevance to brain aging, neurodegenerative disorders, and longevity. Antioxid Redox Signal, 8:444–477. 2006.
97.
CalabreseV, GuaglianoE, SapienzaM, PanebiancoM, CalafatoS, PuleoE, PennisiG, MancusoC, ButterfieldAD, Giuffrida StellaAM. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem Research, 32:757–773. 2007.
98.
CalabreseV, MancusoC, RavagnaA, PerluigiM, CiniC, De MarcoC, ButterfieldD, Giuffrida StellaAM. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state. J Neurochem, 101:709–717. 2007.
99.
CalabreseV, MancusoC, CalvaniM, RizzarelliE, ButterfieldDA, Giuffrida StellaAM. Nitric oxide in the CNS: neuroprotection versus neurotoxicity. Nat Neurosci, 8:766–775. 2007.
100.
CalabreseV, CorneliusC, MancusoC, PennisiG, CalafatoS, BelliaF, BatesTE, Giuffrida StellaAM, SchapiraT, Dinkova KostovaAT, RizzarelliE. Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res, 33:2444–2471. 2008.
101.
CalabreseV, SignorileA, CorneliusC, MancusoC, ScapagniniG, VentimigliaB, RagusaN, Dinkova-KostovaA. Practical approaches to investigate redox regulation of heat shock protein expression and intracellular glutathione redox state. Methods Enzymol, 441:83–110. 2008.
102.
CalabreseV, BatesTE, MancusoC, CorneliusC, VentimigliaB, CambriaMT, Di RenzoL, De LorenzoA, Dinkova-KostovaAT. Curcumin and the cellular stress response in free radical-related diseases. Mol Nutr Food Res, 52:1062–1073. 2008.
103.
CalabreseV, ButterfieldDA, StellaAM. Aging and oxidative stress response in the CNS. Development and Aging Changes in the Nervous System. Handbook of Neurochemistry and Molecular Neurobiology, 3rdAbelL, ReginoP-PJ, SteffenR. New York: Springer, 2008; 128–234.
104.
CalabreseV, CorneliusC, MancusoC, IentileR, StellaAM, ButterfieldDA. Redox homeostasis and cellular stress response in aging and neurodegeneration. Methods Mol. Biol., 610:285–308. 2010.
105.
CalabreseV, CalafatoS, CorneliusC, MancusoC, Dinkova-KostovaA. Heme oxygenase: a master vitagene involved in cellular stress response. Enzymes and the Cellular Fight Against Oxidation. EleuteriAM. Research Signpost: 37/661 (2), Fort P.O., Trivandrum-695 023, Kerala, India, 2008.
106.
CalabreseV, CorneliusC, MancusoC, BaroneE, CalafatoS, BatesT, RizzarelliE, Dinkova-KostovaAT. Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front Biosci, 14:376–397. 2009.
107.
CalabreseV, CorneliusC, Dinkova-KostovaAT, CalabreseEJ. Vitagenes, cellular stress response and acetylcarnitine: relevance to hormesis. Biofactors, 35:146–160. 2009.
108.
CalabreseV, CorneliusC, RizzarelliE, OwenJB, Dinkova-KostovaAT, ButterfieldDA. Nitric oxide in cell survival: a Janus molecule. Antioxid Redox Signal, 11:2717–2739. 2009.
109.
CalabreseV, PerluigiM, CorneliusC, CocciaR, Di DomenicoF, MancusoC, PenniniG, Dinkova-KostovaAT. Phenolics in aging and neurodegenerative disorders. Phenolic Compounds of Plant Origin and Health: The Biochemistry behind their Nutritional and Pharmacological Value. FragaCG. New York: Wiley & Sons, 2009; 427–451.
110.
CalderwoodSK, MurshidA, PrinceT. The shock of aging: molecular chaperones and the heat shock response in longevity and aging—a mini-review. Gerontology, 55:550–558. 2009.
111.
CalkinsMJ, JakelRJ, JohnsonDA, ChanK, KanYW, JohnsonJA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci USA, 102:244–249. 2005.
112.
CalkinsMJ, JohnsonDA, TownsendJA, VargasMR, DowellJA, WilliamsonTP, KraftAD, LeeJM, LiJ, JohnsonJA. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signal, 11:497–508. 2009.
CamandolaS, MattsonMP. Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression. J Neurosci Res, 61:134–139. 2000.
116.
CedergreenN, StreibigJC, KudskP, MathiassenSK, DukeSO. The occurrence of hormesis in plants and algae. Dose Response, 5:150–162. 2007.
117.
ChanK, LuR, ChangJC, KanYW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci USA, 93:13943–13948. 1996.
118.
ChanSL, FuW, ZhangP, ChengA, LeeJ, KokameK, MattsonMP. Herp stabilizes neuronal Ca2+ homeostasis and mitochondrial function during endoplasmic reticulum stress. J Biol Chem, 279:28733–28743. 2004.
119.
ChenC, XinH, ZhuY. Hydrogen sulfide: third gaseous transmitter, but with great pharmacological potential. Acta Pharmacol Sin, 1709–1716. 2007.
120.
ChenL, FeanyMB. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a drosophila model of Parkinson's disease. Nat Neurosci, 8:657–663. 2005.
121.
ChenP, SunB, ChenH, WangG, PanS, KongR, BaiX, WangS. Effects of carbon monoxide releasing molecule-liberated CO on severe acute pancreatitis in rats. Cytokine, 49:15–23. 2010.
122.
ChenPC, VargasMR, PaniAK, SmeyneRJ, JohnsonDA, KanYW, JohnsonJA. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc Natl Acad Sci USA, 106:2933–2938. 2009.
123.
ChengB, MattsonMP. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J Neurosci, 12:1558–1566. 1992.
124.
ChigurupatiS, SonTG, HyunDH, LathiaJD, MughalMR, SavellJ, LiSC, NagarajuGP, ChanSL, ArumugamTV, MattsonMP. Lifelong running reduces oxidative stress and degenerative changes in the testes of mice. J Endocrinol, 199:333–341. 2008.
125.
ChongZZ, LinSH, LiF, MaieseK. The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated “anti-apoptotic” pathways. Curr Neurovasc Res, 2:271–285. 2005.
126.
ChouYH, HoFM, LiuDZ, LinSY, TsaiLH, ChenCH, HoYS, HungLF, LiangYC. The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. Int J Biochem Cell Biol, 37:604–615. 2005.
127.
ChuehS-C, GuhJ-H, ChenJ, LaiM-K, TengC-M. Dual effects of ouabain on the regulation of proliferation and apoptosis in human prostatic smooth muscle cells. J Urol, 166:347–353. 2001.
128.
ChungHT, ChoiBM, KwonYG, KimYM. Interactive relations between nitric oxide (NO) and carbon monoxide (CO): heme oxygenase-1/CO pathway is a key modulator in NO-mediated antiapoptosis and anti-inflammation. Methods Enzymo, 441:329–338. 2008.
129.
ChungKC, SungJY, AhnW, RhimH, OhTH, LeeMG, AhnYS. Intracellular calcium mobilization induces immediate early gene pip92 via Src and mitogen-activated protein kinase in immortalized hippocampal cells. J Biol Chem, 276:2132–2138. 2001.
130.
ClementsCM, McNallyRS, ContiBJ, MakTW, TingJP. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA, 103:15091–15096. 2006.
131.
ClerenC, CalingasanNY, ChenJ, BealMF. Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J Neurochem, 94:995–1004. 2005.
132.
CohenE, DillinA. The insulin paradox: aging, proteotoxicity and neurodegeneration. Nat Rev Neurosci, 9:759–767. 2008.
ConneyAH, MillerEC, MillerJA. The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res, 16:450–459. 1956.
135.
CookRR, CalabreseEJ. The importance of hormesis to public health. Environ Health Perspect, 114:1631–1635. 2006Reprinted in: Cienc Saude Colet 12: 955–963, 2007.
136.
CorsonTW, CrewsCM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell, 130:769–774. 2007.
137.
CrabtreeHG. Anti-carcinogenesis. Br Med Bull, 4:345–348. 1947.
138.
CrabtreeHG. Influence of unsaturated dibasic acids on the induction of skin tumors by chemical carcinogens. Cancer Res, 5:346–351. 1945.
139.
CsermelyP, SötiC, BlatchGL. Chaperones as parts of cellular networks. Adv Exp Med Biol, 594:55–63. 2007.
140.
CutlerRG, MattsonMP. Sphingomyelin and ceramide as regulators of development and lifespan. Mech Ageing Dev, 122:895–908. 2001.
141.
CutlerRG, PedersenWA, CamandolaS, RothsteinJD, MattsonMP. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol, 52:448–457. 2002.
142.
CutlerRG, KellyJ, StorieK, PedersenWA, TammaraA, HatanpaaK, TroncosoJC, MattsonMP. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease. Proc Natl Acad Sci USA, 101:2070–2075. 2004.
143.
CuttlerJM. What becomes of nuclear risk assessment in light of radiation hormesis?Dose Response, 5:80–90. 2007.
144.
Dali-YoucefN, LagougeM, FroelichS, KoehlC, SchoonjansK, AuwerxJ. Sirtuins: the “magnificent seven,” function, metabolism and longevity. Ann Med, 39:335–345. 2007.
145.
De LongMJ, ProchaskaHJ, TalalayP. Tissue-specific induction patterns of cancer-protective enzymes in mice by tert-butyl-4-hydroxyanisole and related substituted phenols. Cancer Res, 45:546–551. 1985.
146.
De LongMJ, ProchaskaHJ, TalalayP. Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens. Proc Natl Acad Sci USA, 83:787–791. 1986.
147.
DelgadoM, VarelaN, Gonzalez-ReyE. Vasoactive intestinal peptide protects against beta-amyloid-induced neurodegeneration by inhibiting microglia activation at multiple levels. Glia, 56:1091–1103. 2008.
148.
DenneryPA. Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul, 36:181–199. 2000.
149.
DerP, CuiJ, DasDK. Role of lipid rafts in ceramide and nitric oxide signaling in the ischemic and preconditioned hearts. J Mol Cell Cardiol, 40:313–320. 2006.
150.
Di StasiAM, MallozziC, MacchiaG, MauraG, PetrucciTC, MinettiM. Peroxynitrite affects exocytosis and SNARE complex formation and induces tyrosine nitration of synaptic proteins. J Neurochem, 82:420–429. 2002.
151.
Dinkova-KostovaAT, TalalayP. Relation of structure of curcumin analogs to their potencies as inducers of phase 2 detoxification enzymes. Carcinogenesis, 20:911–914. 1999.
152.
Dinkova-KostovaAT, TalalayP. Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radic Biol Med, 29:231–240. 2000.
153.
Dinkova-KostovaAT, MassiahMA, BozakRE, HicksRJ, TalalayP. Potency of Michael reaction acceptors as inducers of enzymes that protect against carcinogenesis depends on their reactivity with sulfhydryl groups. Proc Natl Acad Sci USA, 98:3404–3409. 2001.
154.
Dinkova-KostovaAT, HoltzclawWD, ColeRN, ItohK, WakabayashiN, KatohY, YamamotoM, TalalayP. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA, 99:11908–11913. 2002.
155.
Dinkova-KostovaAT, FaheyJW, TalalayP. Chemical structures of inducers of nicotinamide quinone oxidoreductase 1 (NQO1)Methods Enzymol, 382:423–448. 2004.
156.
Dinkova-KostovaAT, HoltzclawWD, KenslerTW. The role of Keap1 in cellular protective responses. Chem Res Toxicol, 18:1779–1791. 2005.
157.
Dinkova-KostovaAT, LibyKT, StephensonKK, HoltzclawWD, GaoX, SuhN, WilliamsC, RisingsongR, HondaT, GribbleGW, SpornMB, TalalayP. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. Proc Natl Acad Sci USA, 102:4584–4589. 2005.
158.
Dinkova-KostovaAT, JenkinsSN, FaheyJW, YeL, WehageSL, LibyKT, StephensonKK, WadeKL, TalalayP. Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts. Cancer Lett, 240:243–252. 2006.
159.
Dinkova-KostovaAT. The isothiocyanate sulforaphane induces the phase 2 response by signaling of the Keap1-Nrf2-ARE pathway: implications for dietary protection against cancer. Dietary Modulation of Cell Signaling Pathways. SurhYJ, DongZ, CadenasE, PackerL. Boca Raton, FL: CRC Press, 2008; 205–229.
160.
Dinkova-KostovaAT, TalalayP. Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52 Suppl, 1:S128–S138. 2008.
161.
DioumEM, ChenR, AlexanderMS, ZhangQ, HoggRT, GerardRD, GarciaJA. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science, 324:1289–1293. 2009.
162.
DirnaglU, MeiselA. Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?Neuropharmacology, 55:334–344. 2008.
163.
DoréS, TakahashiM, FerrisCD, ZakharyR, HesterLD, GuastellaD, SnyderSH. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc Natl Acad Sci USA, 96:2445–2450. 1999.
164.
DouglasPM, CyrDM. Interplay between protein homeostasis networks in protein aggregation and proteotoxicity. Biopolymers, 93:229–236. 2010.
165.
DuY, WootenMC, GearingM, WootenMW. Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease. Free Radic Biol Med, 46:492–501. 2009.
166.
DuanW, MattsonMP. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J Neurosci Res, 57:195–206. 1999.
167.
EatonDL, KlaassenCD. Principles of toxicology. Casarett and Doull's Toxicology: The Basic Science of Poisons, 6thKlaassenCD. New York: McGraw-Hill, 2003; 6–20.
168.
EkdahlCT, KokaiaZ, LindvallO. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience, 158:1021–1029. 2009.
FaheyJW, Dinkova-KostovaAT, StephensonKK, TalalayP. The “Prochaska” microtiter plate bioassay for inducers of NQO1. Methods Enzymol, 382:243–258. 2004.
171.
FangJ, LuJ, HolmgrenA. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem, 280:25284–25290. 2005.
172.
FerrariR, GuardigliG, MeleD, PercocoGF, CeconiC, CurelloS. Oxidative stress during myocardial ischaemia and heart failure. Curr Pharm Des, 10:1699–16711. 2004.
173.
FloodJF, SmithGE, CherkinA. Memory retention—enhancement by cholinergic drug-combinations in mice. Gerontologist, 22:230–231. 1982.
174.
FloodJF, SmithGE, CherkinA. Memory retention—potentiation of cholinergic drug-combinations in mice. Neurobiol Aging, 4:37–43. 1983.
175.
FloodJF, SmithGE, CherkinA. Memory retention—enhancement by synergistic oral cholinergic drug-combination in mice. Gerontol, 24:149. 1984.
176.
FloodJF, SmithGE, CherkinA. Memory enhancement—supra-additive effect of subcutaneous chlolinergic drug-combinations in mice. Psychopharmacology, 86:61–67. 1985.
177.
ForquerI, CovianR, BowmanMK, TrumpowerBL, KramerDM. Similar transition states mediate the Q-cycle and superoxide production by the cytochrome bc1 complex. J Biol Chem, 281:38459–38465. 2006.
178.
FosterKA, GaleffiF, GerichFJ, TurnerDA, MüllerM. Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog Neurobiol, 79:136–171. 2006.
179.
FosterMW, HessDT, StamlerJS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med, 15:391–404. 2009.
180.
FrankfurtOS, LipchinaLP, BuntoTV, EmanuelNM. Effect of 4-methyl-2,6-di-tert-butylphenol (Ionol) on induction of liver tumors in rats. Byull Eksp Biol Med USSR, 64:86–88. 1967.
181.
FriebeA, KoeslingD. The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide, 21:149–156. 2009.
182.
FrilingRS, BensimonA, TichauerY, DanielV. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc Natl Acad Sci USA, 87:6258–6262. 1990.
183.
Gerhart-HinesZ, RodgersJT, BareO, LerinC, KimSH, MostoslavskyR, AltFW, WuZ, PuigserverP. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J, 26:1913–1923. 2007.
184.
GerichFJ, FunkeF, HildebrandtB, FasshauerM, MüllerM. H2O2—mediated modulation of cytosolic signaling and organelle function in rat hippocampus. Pflugers Arch, 458:937–952. 2009.
185.
GidalevitzT, KikisEA, MorimotoRI. A cellular perspective on conformational disease: the role of genetic background and proteostasis networks. Curr Opin Struct Biol, 20:23–32. 2010.
GlaumSR, MillerRJ. Zinc protoporphyrin-IX blocks the effects of metabotropic glutamate receptor activation in the rat nucleus tractus solitarii. Mol Pharmacol, 43:965–969. 1993.
GoloubinoffP, De Los RiosP. The mechanism of Hsp70 chaperones: (entropic) pulling the models together. Trends Biochem Sci, 32:372–380. 2007.
190.
GonzalezDR, TreuerA, SunQA, StamlerJS, HareJM. S-nitrosylation of cardiac ion channels. J Cardiovasc Pharmacol, 54:188–195. 2009.
191.
GoodmanY, MattsonMP. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J Neurochem, 66:869–872. 1996.
192.
GopalakrishnaR, GundimedaU, SchiffmanJE, McNeillTH. A direct redox regulation of protein kinase C isoenzymes mediates oxidant-induced neuritogenesis in PC12 cells. J Biol Chem, 283:14430–14444. 2008.
193.
GraserT, VedernikovYP, LiDS. Study on the mechanism of carbon monoxide induced endotheliumindependent relaxation in porcine coronary artery and vein. Biomed Biochim Acta, 49:293–296. 1990.
194.
GreenKN, SteffanJS, Martinez-CoriaH, SunX, SchreiberSS, ThompsonLM, LaFerlaFM. Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci, 28:11500–11510. 2008.
195.
GrehantN. Le gas du sang. Paris, 1894.
196.
GuerreiroS, ToulorgeD, HirschE, MarienM, SokoloffP, MichelPP. Paraxanthine, the primary metabolite of caffeine, provides protection against dopaminergic cell death via stimulation of ryanodine receptor channels. Mol Pharmacol, 74:980–989. 2008.
197.
HalagappaVK, GuoZ, PearsonM, MatsuokaY, CutlerRG, LaferlaFM, MattsonMP. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis, 26:212–220. 2007.
HartingK, KnöllB. SIRT2-mediated protein deacetylation: an emerging key regulator in brain physiology and pathology. Eur J Cell Biol, 89:262–269. 2010.
200.
HayesJD, McMahonM. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci, 34:176–188. 2009.
201.
HipkissAR. On why decreasing protein synthesis can increase lifespan. Mech Ageing Dev, 128:412–414. 2007.
202.
HipkissAR. NAD + availability and proteotoxicity. Neuromol Med, 11:97–100. 2009.
203.
HishiyaA, TakayamaS. Molecular chaperones as regulators of cell death. Oncogene, 27:6489–6506. 2008.
204.
HoffmannGR. A perspective on the scientific, philosophical, and policy dimensions of hormesis. Dose Response, 7:1–51. 2009.
205.
HoltzclawWD, Dinkova-KostovaAT, TalalayP. Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. Adv Enzyme Regul, 44:335–367. 2004.
206.
HubbsAF, BenkovicSA, MillerDB, O'CallaghanJP, BattelliL, Schwegler-BerryD, MaQ. Vacuolar leukoencephalopathy with widespread astrogliosis in mice lacking transcription factor Nrf2. Am J Pathol, 170:2068–2076. 2007.
207.
HuddlestonAT, TangW, TakeshimaH, HamiltonSL, KlannE. Superoxide-induced potentiation in the hippocampus requires activation of ryanodine receptor type 3 and ERK. J Neurophysiol, 99:1565–1571. 2008.
208.
HugginsC, FukunishiR. Induced protection of adrenal cortex against 7,12-dimethylbenz[α]anthracene. Influence of ethionine. Induction of menadione reductase. Incorporation of thymidine-H3. J Exp Med, 119:923–942. 1964.
209.
HugginsC, PatakiJ. Aromatic azo derivatives preventing mammary cancer and adrenal injury from 7,12-dimethylbenz(a)anthracene. Proc Natl Acad Sci USA, 53:791–796. 1965.
210.
HyunDH, HernandezJO, MattsonMP, de CaboR. The plasma membrane redox system in aging. Ageing Res Rev, 5:209–220. 2006.
211.
HyunDH, EmersonSS, JoDG, MattsonMP, de CaboR. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci USA, 103:19908–19912. 2006.
212.
HyunDH, HuntND, EmersonSS, HernandezJO, MattsonMP, de CaboR. Up-regulation of plasma membrane-associated redox activities in neuronal cells lacking functional mitochondria. J Neurochem, 100:1364–1374. 2007.
213.
InnamoratoNG, RojoAI, García-YagüeAJ, YamamotoM, de CeballosML, CuadradoA. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol, 181:680–689. 2008.
214.
IshigamiM, HirakiK, UmemuraK, OgasawaraY, IshiiK, KimuraH. A source of hydrogen sulfide and a mechanism of its release in the brain. Antioxid Redox Signal, 11:205–214. 2009.
215.
ItohK, ChibaT, TakahashiS, IshiiT, IgarashiK, KatohY, OyakeT, HayashiN, SatohK, HatayamaI, YamamotoM, NabeshimaY. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun, 236:313–322. 1997.
216.
ItohK, WakabayashiN, KatohY, IshiiT, IgarashiK, EngelJD, YamamotoM. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev, 13:76–86. 1999.
217.
JiangF, ZhangZG, KatakowskiM, RobinAM, FaberM, ZhangF, ChoppM. Angiogenesis induced by photodynamic therapy in normal rat brains. Photochem Photobiol, 79:494–498. 2004.
218.
JiaoJ, HuangX, Feit-LeithmanRA, NeveRL, SniderW, DarttDA, ChenDF. Bcl-2 enhances Ca(2+) signaling to support the intrinsic regenerative capacity of CNS axons. EMBO J, 24:1068–1078. 2005.
219.
JohnsonJA, JohnsonDA, KraftAD, CalkinsMJ, JakelRJ, VargasMR, ChenPC. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann NY Acad Sci, 1147:61–69. 2008.
220.
JohnsonJB, SummerW, CutlerRG, MartinB, HyunDH, DixitVD, PearsonM, NassarM, TelljohannR, MaudsleyS, CarlsonO, JohnS, LaubDR, MattsonMP. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med, 42:665–674. 2007.
KangYH, PezzutoJM. Induction of quinone reductase as a primary screen for natural product anticarcinogens. Methods Enzymol, 382:380–414. 2004.
223.
KapitulnikJ, MainesMD. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends Pharmacol Sci, 30:129–137. 2009.
224.
KapposL, GoldR, MillerDH, MacmanusDG, HavrdovaE, LimmrothV, PolmanCH, SchmiererK, YousryTA, YangM, EraksoyM, MeluzinovaE, RektorI, DawsonKT, SandrockAW, O'NeillGN. BG-12 phase IIb study investigators. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet, 372:1463–1472. 2008.
225.
KellerJN, KindyMS, HoltsbergFW, St. ClairDK, YenHC, GermeyerA, SteinerSM, Bruce-KellerAJ, HutchinsJB, MattsonMP. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci, 18:687–697. 1998.
226.
KellerJN, MattsonMP. Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci, 9:105–116. 1998.
227.
KenslerTW, WakabayashiN, BiswalS. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol, 47:89–116. 2007.
228.
KenslerTW. Chemoprevention by inducers of carcinogen detoxication enzymes. Environ Health Perspect, 105:965–970. 1997.
229.
KimD, NguyenMD, DobbinMM, FischerA, SananbenesiF, RodgersJT, DelalleI, BaurJA, SuiG, ArmourSM, PuigserverP, SinclairDA, TsaiLH. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J, 26:3169–3179. 2007.
230.
KimuraH. Hydrogen sulfide as a neuromodulator. Mol Neurobiol, 26:13–19. 2002.
231.
KimuraH. Hydrogen sulfide as a biological mediator. Antioxid Redox Signal, 7:778–780. 2005.
232.
KitamuroT, TakahashiK, OgawaK, Udono-FujimoriR, TakedaK, FuruyamaK, NakayamaM, SunJ, FujitaH, HidaW, HattoriT, ShiratoK, IgarashiK, ShibaharaS. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem, 278:9125–9133. 2003.
233.
KitaoY, ImaiY, OzawaK, KataokaA, IkedaT, SodaM, NakimawaK, KiyamaH, SternDM, HoriO, WakamatsuK, ItoS, ItoharaS, TakahashiR, OgawaS. Pael receptor induces death of dopaminergic neurons in the substantia nigra via endoplasmic reticulum stress and dopamine toxicity, which is enhanced under condition of parkin inactivation. Hum Mol Genet, 16:50–60. 2007.
KobayashiA, KangMI, WataiY, TongKI, ShibataT, UchidaK, YamamotoM. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol, 26:221–229. 2006.
237.
KobayashiM, YamamotoM. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul, 46:113–140. 2006.
238.
KomatsuM, KurokawaH, WaguriS, TaguchiK, KobayashiA, IchimuraY, SouYS, UenoI, SakamotoA, TongKI, KimM, NishitoY, IemuraS, NatsumeT, UenoT, KominamiE, MotohashiH, TanakaK, YamamotoM. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol, 12:213–223. 2010.
239.
KosakaK, YokoiT. Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98G human glioblastoma cells. Biol Pharm Bull, 26:1620–1622. 2003.
240.
KraftAD, JohnsonDA, JohnsonJA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci, 24:1101–1112. 2004.
241.
KraftAD, LeeJM, JohnsonDA, KanYW, JohnsonJA. Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J Neurochem, 98:1852–1865. 2006.
KrumanII, MattsonMP. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J Neurochem, 72:529–540. 1999.
244.
KurodaK, TakagiK. Physiologically active substance in Capsella bursa-pastoris. Nature, 220:707–708. 1968.
245.
KurodaK, AkaoM. Reduction by fumaric acid of side effects of mitomycin C. Biochem Pharmacol, 29:2839–2844. 1980.
246.
LacassagneA, Buu-HoiNP, RudaliG. Induction of the carcinogenic action produced by a weakly carcinogenic hydrocarbon on a highly active carcinogenic hydrocarbon. Br J Exp Pathol, 26:5–12. 1945.
247.
LagougeM, ArgmannC, Gerhart-HinesZ, MezianeH, LerinC, DaussinF, MessadeqN, MilneJ, LambertP, ElliottP, GenyB, LaaksoM, PuigserverP, AuwerxJ. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 127:1109–1122. 2006.
248.
LavuS, BossO, ElliottPJ, LambertPD. Sirtuins—novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov, 7:841–853. 2008.
249.
LeeJM, ShihAY, MurphyTH, JohnsonJA. NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J Biol Chem, 278:37948–37956. 2003.
250.
LeeSH, BlairIA. Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc Med, 11:148–155. 2001.
251.
LeeM, SchwabC, YuS, McGeerE, McGeerPL. Astrocytes produce the antiinflammatory and neuroprotective agent hydrogen sulfide. Neurobiol Aging, 30:1523–1534. 2009.
252.
LeonarduzziG, ChiarpottoE, BiasiF, PoliG. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol Nutr Food Res, 49:1044–1049. 2005.
253.
LevonenAL, LandarA, RamachandranA, CeaserEK, DickinsonDA, ZanoniG, MorrowJD, Darley-UsmarVM. Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J, 378:373–382. 2004.
LimGP, YangF, ChuTet al.Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci, 20:5709–5714. 2000.
LiuD, ChanSL, de Souza-PintoNC, SlevinJR, WerstoRP, ZhanM, MustafaK, de CaboR, MattsonMP. Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress. Neuromol Med, 8:389–414. 2006.
262.
LiuD, GharaviR, PittaM, GleichmannM, MattsonMP. Nicotinamide prevents NAD + depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD + consumption by SIRT1 may endanger energetically compromised neurons. Neuromol Med, 11:28–42. 2009.
263.
LiuD, PittaM, MattsonMP. Preventing NAD(+) depletion protects neurons against excitotoxicity: bioenergetic effects of mild mitochondrial uncoupling and caloric restriction. Ann NY Acad Sci, 1147:275–282. 2008.
264.
LiuH, Dinkova-KostovaAT, TalalayP. Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles. Proc Natl Acad Sci USA, 105:15926–15931. 2008.
265.
LuM, HuLF, HuG, BianJS. Hydrogen sulfide protects astrocytes against H2O2-induced neural injury via enhancing glutamate uptake. Free Rad Biol Med, 45:1705–1713. 2008.
266.
LuM, KimHE, LiCR, KimS, KwakIJ, LeeYJ, KimSS, MoonJY, KimCH, KimDK, KangHS, ParkJS. Two distinct disulfide bonds formed in human heat shock transcription factor 1 act in opposition to regulate its DNA binding activity. Biochemistry, 47:6007–6015. 2008.
MaZC, HongQ, WangYG, TanHL, XiaoCR, LiangQD, ZhangBL, GaoY. Ferulic acid protects human umbilical vein endothelial cells from radiation induced oxidative stress by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Biol Pharm Bull, 33:29–34. 2010.
269.
MacarioAJ, Conway de MacarioE. Sick chaperones, cellular stress, and disease. N Engl J Med, 353:1489–1501. 2005.
270.
MacarioAJ, Conway de MacarioE. Molecular chaperones: multiple functions, pathologies, and potential applications. Front Biosci, 12:2588–2600. 2007.
271.
MacarioAJ, Conway de MacarioE. Chaperonopathies by defect, excess, or mistake. Ann NY Acad Sci, 1113:178–191. 2007.
272.
MadhavanL, OurednikV, OurednikJ. Neural stem/progenitor cells initiate the formation of cellular networks that provide neuroprotection by growth factor-modulated antioxidant expression. Stem Cells, 26:254–265. 2008.
273.
MainesMD, GibbsPEM. 30 some years of heme oxygenase: From a “molecular wrecking ball” to a “mesmerizing” trigger of cellular events. Biochem Biophys Res Commun, 338:568–577. 2005.
274.
MainesMD. The heme oxygenase system; a regulator of second messenger gases. Annu Rev Pharmacol Toxicol, 37:517–554. 1997.
275.
MalhotraD, ThimmulappaR, Navas-AcienA, SandfordA, ElliottM, SinghA, ChenL, ZhuangX, HoggJ, PareP, TuderRM, BiswalS. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med, 178:592–604. 2008.
276.
MancusoC, PaniG, CalabreseV. Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep, 11:207–213. 2006.
277.
MancusoC, ScapagniniG, CurroD, Giuffrida StellaAM, De MarcoC, ButterfieldDA, CalabreseV. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci, 12:1107–1123. 2007.
278.
MarkRJ, HensleyK, ButterfieldDA, MattsonMP. Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death. J Neurosci, 15:6239–6249. 1995.
279.
MarkRJ, PangZ, GeddesJW, UchidaK, MattsonMP. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci, 17:1046–1054. 1997.
280.
MasoroEJ. Role of hormesis in life extension by caloric restriction. Dose Response, 5:163–173. 2007.
281.
MattsonMP, GoodmanY, LuoH, FuW, FurukawaK. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J Neurosci Res, 49:681–697. 1997.
282.
MattsonMP. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci, 21:53–57. 1998.
283.
MattsonMP, LaFerlaFM, ChanSL, LeissringMA, ShepelPN, GeigerJD. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci, 23:222–229. 2000.
284.
MattsonMP, LiuD. Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Med, 2:215–231. 2002.
285.
MattsonMP. Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res Rev, 2:329–342. 2003.
286.
MattsonMP. Pathways towards and away from Alzheimer's disease. Nature, 430:631–639. 2004.
McCordJM. Superoxide dismutase in aging and disease: an overview. Methods Enzymol, 349:331–341. 2002.
297.
McCoubreyWK, HuangTJ, MainesMD. Heme oxygenase-2 is a hemoprotein and binds heme through heme regulatory motifs that are not involved in heme catalysis. J Biol Chem, 272:12568–12574. 1997.
298.
McMahonM, ItohK, YamamotoM, ChanasSA, HendersonCJ, McLellanLI, WolfCR, CavinC, HayesJD. The Cap‘n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res, 61:3299–3307. 2001.
299.
McMahonM, ThomasN, ItohK, YamamotoM, HayesJD. Dimerization of substrate adaptors can facilitate Cullin-mediated ubiquitylation of proteins by a “tethering” mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J Biol Chem, 281:24756–24768. 2006.
300.
McNallySJ, HarrisonEM, RossJA, GardenOJ, WigmoreSJ. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int J Mol Med, 19:165–172. 2007.
301.
MendesCS, LevetC, ChatelainG, DourlenP, FouilletA, Dichtel-DanjoyML, GambisA, RyooHD, StellerH, MollereauB. ER stress protects from retinal degeneration. EMBO J, 28:1296–1307. 2009.
302.
MichalakM, Robert ParkerJM, OpasM. Ca2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium, 32:269–278. 2002.
303.
MillerCA, CampbellSL, SweattJD. DNA methylation and histone acetylation work in concert to regulate memory formaion and synaptic plasticity. Neurobiol Learn Mem, 89:599–603. 2008.
304.
MillerJA, MillerEC. The carcinogenic aminoazo dyes. Adv Cancer Res, 1:339–396. 1953.
305.
MilneJC, LambertPD, SchenkS, CarneyDP, SmithJJ, GagneDJ, JinL, BossO, PerniRB, VuCB, BemisJE, XieR, DischJS, NgPY, NunesJJ, LynchAV, YangH, GalonekH, IsraelianK, ChoyW, IfflandA, LavuS, MedvedikO, SinclairDA, OlefskyJM, JirousekMR, ElliottPJ, WestphalCH. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 450:712–716. 2007
306.
MitchelREJ. Low doses of radiation are protective in vitro and in vivo: Evolutionary origins. Dose Response, 4:75–90. 2006.
307.
MitchelREJ. Low doses of radiation reduce risk in vivo. Dose Response, 5:1–10. 2007.
308.
MoiP, ChanK, AsunisI, CaoA, KanYW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA, 91:9926–9930. 1994.
309.
MorimotoRI, SantoroMG. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol, 16:833–838. 1998.
310.
MorimotoRI. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev, 12:3788–3796. 1998.
311.
MorimotoRI. Stress, aging, and neurodegenerative disease. New Engl J Med, 355:2254–2255. 2006.
312.
MorimotoRI. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev, 22:1427–1438. 2008.
313.
MothersillC, SeymourCB. Radiation-induced bystander effects and the DNA paradigm: An “out of field” perspective. Mutat Res, 597:5–10. 2006.
314.
MotohashiH, O'ConnorT, KatsuokaF, EngelJD, YamamotoM. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene, 294:1–12. 2002.
315.
MotohashiH, YamamotoM. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol Med, 10:549–557. 2004.
316.
MotterliniR, ForestiR, BassiR, CalabreseV, ClarkJE, GreenCJ. Endothelial Heme oxygenase-1 induction by hypoxia: modulation by inducible nitric oxide synthase (iNOS) and S-nitrosothiols. J Biol Chem, 275:13613–13620. 2000.
317.
MotterliniR, ForestiR, BassiR, GreenCJ. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med, 28:1303–1312. 2000.
318.
MullerP, HrstkaR, CoomberD, LaneDP, VojtesekB. Chaperone-dependent stabilization and degradation of p53 mutants. Oncogene, 27:3371–3383. 2008.
319.
MundayR, MundayCM. Induction of phase II enzymes by aliphatic sulfides derived from garlic and onions: an overview. Methods Enzymol, 382:449–456. 2004.
320.
NaidooN. ER and aging—protein folding and the ER stress response. Ageing Res Rev, 8:150–159. 2009.
321.
NakamuraT, LiptonSA. S-Nitrosylation and uncompetitive/fast off-rate (UFO) drug therapy in neurodegenerative disorders of protein misfolding. Cell Death Differ, 14:1305–1314. 2007.
322.
NapoliC, IgnaroLJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res, 32:1103–1108. 2009.
323.
NavarroA, BoverisA. Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Adv Drug Deliv Rev, 60:1534–1544. 2008.
324.
NguyenT, NioiP, PickettCB. The nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem, 284:13291–13295. 2009.
325.
NguyenT, SherrattPJ, PickettCB. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu Rev Pharmacol Toxicol, 43:233–260. 2003.
326.
NiM, LeeAS. ER chaperones in mammalian development and human diseases. FEBS Lett, 581:3641–3651. 2007.
327.
NieboerC, de HoopD, van LoenenAC, LangendijkPN, van DijkE. Systemic therapy with fumaric acid derivates: new possibilities in the treatment of psoriasis. J Am Acad Dermatol, 20:601–608. 1989.
328.
NisoliE, ClementiE, PaolucciC, CozziV, TonelloC, ScioratiC, BracaleR, ValerioA, FrancoliniM, MoncadaS, CarrubaMO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science, 299:896–893. 2003.
Noyan-AshrafMH, WuL, WangR, JuurlinkBH. Dietary approaches to positively influence fetal determinants of adult health. FASEB J, 20:371–373. 2006.
331.
NystulTG, RothMB. Carbon monoxide-induced suspended animation protects against hypoxic damage in Caenorhabditis elegans. Proc Natl Acad Sci USA, 101:9133–9136. 2004.
332.
OkadaK, ShodaJ, TaguchiK, MaherJM, IshizakiK, InoueY, OhtsukiM, GotoN, TakedaK, UtsunomiyaH, OdaK, WarabiE, IshiiT, OsakaK, HyodoI, YamamotoM. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol, 295:G735–G747. 2008.
333.
OkawaH, MotohashiH, KobayashiA, AburataniH, KenslerTW, YamamotoM. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem Biophys Res Commun, 339:79–88. 2006.
334.
OkunE, GriffioenKJ, LathiaJD, TangSC, MattsonMP, ArumugamTV. Toll-like receptors in neurodegeneration. Brain Res Rev, 59:278–292. 2009.
335.
OnoK, IkemotoM, KawarabayashiT, IkedaM, NishinakagawaT, HosokawaM, ShojiM, TakahashiM, NakashimaM. A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human alpha-synuclein A30P + A53T transgenic mice. Parkinsonism Relat Disord, 15:649–654. 2009.
336.
OsburnWO, YatesMS, DolanPD, ChenS, LibyKT, SpornMB, TaguchiK, YamamotoM, KenslerTW. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice. Toxicol Sci, 104:218–227. 2008.
337.
OtterbeinLE. Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid Redox Signal, 4:309–319. 2002.
338.
OtterbeinLE, SoaresMP, YamashitaK, BachF. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol, 24:449–466. 2003.
OuteiroTF, MarquesO, KazantsevA. Therapeutic role of sirtuins in neurodegenerative disease. Biochim Biophys Acta, 1782:363–369. 2008.
342.
PacchioniAM, ValloneJ, MelendezRI, ShihA, MurphyTH, KalivasPW. Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity. Brain Res, 1127:26–35. 2007.
343.
PadmanabhanB, ScharlockM, TongKI, NakamuraY, KangMI, KobayashiA, MatsumotoT, TanakaA, YamamotoM, YokoyamaS. Purification, crystallization and preliminary X-ray diffraction analysis of the Kelch-like motif region of mouse Keap1. Acta Crystallogr Sect F Struct Biol Crystalliz Commun, 61:153–155. 2005.
344.
PadmanabhanB, TongKI, KobayashiA, YamamotoM, YokoyamaS. Structural insights into the similar modes of Nrf2 transcription factor recognition by the cytoplasmic repressor Keap1. J Synchrotron Radiat, 15:273–276. 2008.
345.
PadmanabhanB, TongKI, OhtaT, NakamuraY, ScharlockM, OhtsujiM, KangMI, KobayashiA, YokoyamaS, YamamotoM. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. Mol Cell, 21:689–700. 2006.
346.
PanahianN, YoshiuraM, MainesMD. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem, 72:1187–1203. 1999.
347.
ParkMK, ChoiYM, KangYK, PetersenOH. The endoplasmic reticulum as an integrator of multiple dendritic events. Neuroscientist, 14:68–77. 2008.
PfisterJA, MaC, MorrisonBE, D'MelloSR. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS One, 3:e4090. 2008.
354.
PiantadosiCA, ZhangJ, LevinED, FolzRJ, SchmechelDE. Apoptosis and delayed neuronal damage after carbon monoxide poisoning in the rat. Exp Neurol, 147:103–114. 1997.
PresteraT, ZhangY, SpencerSR, WilczakCA, TalalayP. The electrophile counterattack response: protection against neoplasia and toxicity. Adv Enzyme Regul, 33:281–296. 1993.
357.
ProchaskaHJ, SantamariaAB. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem, 169:328–336. 1988.
358.
ProchaskaHJ, BregmanHS, De LongMJ, TalalayP. Specificity of induction of cancer protective enzymes by analogues of tert-butyl-4-hydroxyanisole (BHA)Biochem Pharmacol, 34:3909–3914. 1985.
359.
ProchaskaHJ, De LongMJ, TalalayP. On the mechanisms of induction of cancer-protective enzymes: a unifying proposal. Proc Natl Acad Sci USA, 82:8232–8236. 1985.
360.
ProchaskaHJ, SantamariaAB, TalalayP. Rapid detection of inducers of enzymes that protect against carcinogens. Proc Natl Acad Sci USA, 89:2394–2398. 1992.
361.
ProzorovskiT, Schulze-TopphoffU, GlummR, BaumgartJ, SchröterF, NinnemannO, SiegertE, BendixI, BrüstleO, NitschR, ZippF, AktasO. Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol, 10:385–394. 2008.
362.
PrzemyslawW, VaarmannA, ChoubeyV, SafiulinaD, LiivJ, KuumM, KaasikA. PGC-1[alpha] AND PGC-1[beta] regulate mitochondrial density in neurons. J Biol Chem, 284:21379–21385. 2009.
363.
QinW, YangT, HoL, ZhaoZ, WangJ, ChenL, ZhaoW, ThiyagarajanM, MacGroganD, RodgersJT, PuigserverP, SadoshimaJ, DengH, PedriniS, GandyS, SauveAA, PasinettiGM. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem, 281:21745–21754. 2006.
Ramesh BabuJ, Lamar SeibenhenerM, PengJ, StromAL, KemppainenR, CoxN, ZhuH, WootenMC, Diaz-MecoMT, MoscatJ, WootenMW. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem, 106:107–120. 2008.
366.
RandallWA, PriceCW, WelchH. Demonstration of hormesis (increase in fatality rate) by penicillin. Am J Pub Health, 37:421–425. 1947.
367.
RedpathJL. Suppression of neoplastic transformation in vitro by low doses of low LET radiation. Dose Response, 4:302–308. 2006.
368.
RedpathJL, ElmoreE. Radiation-induced neoplastic transformation in vitro, hormesis and risk assessment. Dose Response, 5:123–130. 2007.
369.
ReismanSA, YeagerRL, YamamotoM, KlaassenCD. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species. Toxicol Sci, 108:35–47. 2009.
370.
RobertsonCH, GriffinAC, RichardsonHL. The inhibitory action of p-hydroxypropiophenone on hepatic carcinoma induced by azo dye. J Natl Cancer Inst, 15:519–527. 1954.
371.
RiegelB, WartmanWB, HillWT, ReebBB, ShubikP, StangerDW. Delay of methylcholanthrene skin carcinogenesis in mice by 1,2,5,6-dibenzofluorene. Cancer Res, 11:301–303. 1951.
372.
RistowM, ZarseK, OberbachA, KlötingN, BirringerM, KiehntopfM, StumvollM, KahnCR, BlüherM. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA, 106:8665–8670. 2009.
373.
RossiA, TrottaE, BrandiR, ArisiI, Coccia, SantoroMG. AIRAP: a new human Heat shock gene regulated by Heat shock factor 1. J Biol Chem, 285:13607–13615. 2010.
374.
RothMB, NystulT. Buying time in suspended animation. Sci Am, 292:48–55. 2005.
375.
RushmoreTH, PickettCB. Transcriptional regulation of the rat glutathione S-transferase Ya subunit gene. Characterization of a xenobiotic-responsive element controlling inducible expression by phenolic antioxidants. J Biol Chem, 265:14648–14653. 1990.
376.
RushmoreTH, MortonMR, PickettCB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem, 266:11632–11639. 1991.
377.
SachdevS, DaviesKJ. Production, detection, and adaptive responses to free radicals in exercise. Free Radic Biol Med, 44:215–223. 2008.
SakaiK, NomuraT, InaY. Enhancement of bio-protective functions by low dose/dose-rate radiation. Dose Response, 4:327–332. 2006.
382.
SalminenA, KauppinenA, SuuronenT, KaarnirantaK. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation?Bioessays, 30:939–942. 2008.
383.
SalminenA, KaarnirantaK. SIRT1 regulates the ribosomal DNA locus: epigenetic candles twinkle longevity in the Christmas tree. Biochem Biophys Res Commun, 378:6–9. 2009.
384.
SandurSK, DeorukhkarA, PandeyMK, PabónAM, ShentuS, GuhaS, AggarwalBB, KrishnanS. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys, 75:534–542. 2009.
385.
SatohT, LiptonSA. Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci, 30:37–45. 2007.
386.
SatohT, KosakaK, ItohK, KobayashiA, YamamotoM, ShimojoY, KitajimaC, CuiJ, KaminsJ, OkamotoS, IzumiM, ShirasawaT, LiptonSA. Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J Neurochem, 104:1116–1131. 2008.
387.
SatohT, OkamotoSI, CuiJ, WatanabeY, FurutaK, SuzukiM, TohyamaK, LiptonSA. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophilic phase II inducers. Proc Natl Acad Sci USA, 103:768–773. 2006.
388.
SatohT, SaitohS, HosakaM, KosakaK. Simple ortho- and para-hydroquinones as compounds neuroprotective against oxidative stress in a manner associated with specific transcriptional activation. Biochem Biophys Res Commun, 379:537–541. 2009.
389.
ScapagniniG, ButterfieldDA, ColombritaC, SultanaR, PascaleA, CalabreseV. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress. Antioxid Redox Signal, 6:811–818. 2004.
SchillingS, GoelzS, LinkerR, LuehderF, GoldR. Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin Exp Immunol, 145:101–107. 2006.
392.
SchimrigkS, BruneN, HellwigK, LukasC, BellenbergB, RieksM, HoffmannV, PöhlauD, PrzuntekH. Oral fumaric acid esters for the treatment of active multiple sclerosis: an open-label, baseline-controlled pilot study. Eur J Neurol, 13:604–610. 2006.
393.
SchipperHM. Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol, 35:821–830. 2000.
394.
SchipperHM, SongW, ZukorH, HascaloviciJR, ZeligmanD. Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J Neurochem, 110:469–485. 2009.
395.
SchmidtU, HolsboerF, ReinT. Role of the hsp70 cochaperone BAG1 in glucocorticoid receptor function and stress-related diseases. Proc Natl Acad Sci USA, 105:E101. 2008.
ScottBR, DiPalmaJ. Sparsely ionizing diagnostic and natural background radiations are likely preventing cancer and other genomic-instability-associated diseases. Dose Response, 5:230–255. 2006.
398.
ScottBR. It's time for a new low-dose-radiation risk assessment paradigm—one that acknowledges hormesis. Dose Response, 6:333–351. 2008.
399.
SergentO, GriffonB, MorelI, ChevanneM, DubosMP, CillardP, CillardJ. Effect of nitric oxide on iron-mediated oxidative stress in primary rat hepatocyte culture. Hepatology, 25:122–127. 1977.
400.
SethiG, AhnKS, PandeyMK, AggarwalBB. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-κB activation. Blood, 109:2727–2735. 2007.
401.
SethiJM, OtterbeinLE, ChoiAM. Differential modulation of exogenous carbon monoxide of TNF-alpha stimulated mitogen-activated protein kinases n rat pulmonary artery endothelial cells. Antioxid Redox Signal, 4:241–248. 2002.
ShihAY, ErbH, MurphyTH. Dopamine activates Nrf2-regulated neuroprotective pathways in astrocytes and meningeal cells. J Neurochem, 101:109–119. 2007.
406.
ShihAY, ImbeaultS, BarakauskasV, ErbH, JiangL, LiP, MurphyTH. Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem, 280:22925–22936. 2005.
407.
ShihAY, JohnsonDA, WongG, KraftAD, JiangL, ErbH, JohnsonJA, MurphyTH. Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J Neurosci, 23:3394–33940. 2003.
408.
ShihAY, LiP, MurphyTH. A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci, 25:10321–10335. 2005.
409.
ShimazuT, HorinouchiS, YoshidaM. Multiple histone deacetylases and the CREB-binding protein regulate pre-mRNA 3′-end processing. J Biol Chem, 282:4470–4478. 2007.
410.
SiebertA, DesaiV, ChandrasekaranK, FiskumG, JafriMS. Nrf2 activators provide neuroprotection against 6-hydroxydopamine toxicity in rat organotypic nigrostriatal cocultures. J Neurosci Res, 87:1659–1669. 2009.
411.
SiemsW, CarluccioF, RadenkovicS, GruneT, HamplH. Oxidative stress in renal anemia of hemodialysis patients is mitigated by epoetin treatment. Kidney Blood Press Res, 28:295–301. 2005.
412.
SiowRC, IshiiT, MannGE. Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2/ARE transcription pathway. Redox Rep, 12:11–15. 2007.
413.
SirabellaR, SecondoA, PannaccioneA, ScorzielloA, ValsecchiV, AdornettoA, BiloL, Di RenzoG, AnnunziatoL. Anoxia-induced NF-kappaB-dependent upregulation of NCX1 contributes to Ca2+ refilling into endoplasmic reticulum in cortical neurons. Stroke, 40:922–929. 2009.
414.
SjorstrandT. Endogenous formation of carbon monoxide in man under normal and pathological conditions. Scand J Clin Lab Invest, 1:201–214. 1949.
415.
SmithEL, SchuchmanEH. The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J, 22:3419–3431. 2008.
416.
SötiC, CsermelyP. Aging cellular networks: chaperones as major participants. Exp Gerontol, 42:113–119. 2007.
417.
SötiC, CsermelyP. Protein stress and stress proteins: implications in aging and disease. J Biosci, 32:511–515. 2007.
SparninsVL, BaranyG, WattenbergLW. Effects of organosulfur compounds from garlic and onions on benzo[a]pyrene-induced neoplasia and glutathione S-transferase activity in the mouse. Carcinogenesis, 9:131–134. 1988.
420.
SpencerSR, WilczakCA, TalalayP. Induction of glutathione transferases and NAD(P)H:quinone reductase by fumaric acid derivatives in rodent cells and tissues. Cancer Res, 50:7871–7875. 1990.
421.
SpencerSR, XueLA, KlenzEM, TalalayP. The potency of inducers of NAD(P)H:(quinone-acceptor) oxidoreductase parallels their efficiency as substrates for glutathione transferases. Structural and electronic correlations. Biochem J, 1:711–717. 1991.
422.
StanfordSJ, WaltersMJ, MitchellJA. Carbon monoxide inhibits endothelin-1 release by human pulmonary artery smooth muscle cells. Eur J Pharmacol, 486:349–352. 2004.
423.
StebbingARD. Effects of low metal levels on a clonal hydroid. J Marine Biol Assoc UK, 56:977–994. 1976.
424.
StebbingARD. Hormesis—the stimulation of growth by low-levels of inhibitors. Sci Total Environ, 22:213–234. 1982.
425.
StockerR, YamamotoY, McDonaghAF, GlazerAN, AmesBN. Bilirubin is an antioxidant of possible physiological importance. Science, 235:1043–1046. 1987.
426.
StoofTJ, FlierJ, SampatS, NieboerC, TensenCP, BoorsmaDM. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br J Dermatol, 144:1114–1120. 2001.
427.
SulimanHB, CarrawayMS, TatroLG, PiantadosiCA. A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci, 120:299–308. 2007.
428.
SummersSA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res, 45:42–72. 2006.
429.
SunMM, BuH, LiB, YuJX, GuoYS, LiCY. Neuroprotective potential of phase II enzyme inducer diallyl trisulfide. Neurol Res, 31:23–27. 2009.
430.
SuzukiK, KoikeT. Resveratrol abolishes resistance to axonal degeneration in slow Wallerian degeneration (WldS) mice: activation of SIRT2, an NAD-dependent tubulin deacetylase. Biochem Biophys Res Commun, 359:665–671. 2007
431.
SykesPJ, MorleyAA, HookerAM. The pKZ1 recombination mutation assay: a sensitive assay for low dose studies. Dose Response, 4:91–105. 2006.
432.
SykesPJ, DayTK. Requirements for identification of low dose and non-linear mutagenic responses to ionizing radiation. Dose Response, 5:308–314. 2007.
433.
SzabadiE. Model of 2 functionally antagonistic receptor populations activated by same agonist. J Theor Biol, 69:101–112. 1977.
434.
SzabóC. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov, 6:917–935. 2007
435.
TalalayP, BatzingerRP, BensonAM, BuedingE, ChaYN. Biochemical studies on the mechanisms by which dietary antioxidants suppress mutagenic activity. Adv Enzyme Regul, 17:23–36. 1978.
436.
TalalayP, BensonAM. Elevation of quinone reductase activity by anticarcinogenic antioxidants. Adv Enzyme Regul, 20:287–300. 1982.
437.
TalalayP, De LongMJ, ProchaskaHJ. Identification of a common chemical signal regulating the induction of enzymes that protect against chemical carcinogenesis. Proc Natl Acad Sci USA, 85:8261–8265. 1988.
438.
TalalayP. Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors, 12:5–11. 2000.
439.
TalalayP, Dinkova-KostovaAT, HoltzclawWD. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv Enzyme Regul, 43:121–134. 2003.
440.
TalalayP, Dinkova-KostovaAT. Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates. Methods Enzymol, 382:355–364. 2004.
441.
TalalayP, FaheyJW, HealyZR, WehageSL, BenedictAL, MinC, Dinkova-KostovaAT. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc Natl Acad Sci USA, 104:17500–17505. 2007.
442.
TanBH, WongPT, BianJS. Hydrogen sulfide: a novel signaling molecule in the central nervous system. Neurochem Int, 56:3–10. 2010.
443.
TangermanA. Measurement and biological significance of the volatile sulfur compounds hydrogen sulfide, methanethiol and dimethyl sulfide in various biological matrices. J Chromatogr B, 877:3366–3377. 2009
444.
TeitenMH, EifesS, ReuterS, DuvoixA, DicatoM, DiederichM. Gene expression profiling related to anti-inflammatory properties of curcumin in K562 leukemia cells. Ann NY Acad Sci, 1171:391–398. 2009.
445.
TenhunenR, MarverHS, SchmidR. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem, 244:6388–6394. 1969.
ThomER, FisherD, XuYA, NotarfrancescoK, IschiropoulosH. Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci USA, 97:1305–1310. 2000.
448.
ThongH-Y, MaibachHI. Hormesis [biological effects of low level exposure (BELLE)] and dermatology. Dose Response, 6:1–15. 2008.
449.
TongKI, KobayashiA, KatsuokaF, YamamotoM. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol Chem, 387:1311–1320. 2006.
450.
TongKI, KatohY, KusunokiH, ItohK, TanakaT, YamamotoM. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol, 26:2887–2900. 2006.
451.
TongKI, PadmanabhanB, KobayashiA, ShangC, HirotsuY, YokoyamaS, YamamotoM. Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response. Mol Cell Biol, 27:7511–7521. 2007.
452.
TrottA, WestJD, KlaićL, WesterheideSD, SilvermanRB, MorimotoRI, MoranoKA. Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. Mol Biol Cell, 19:1104–1112. 2008.
453.
TurcanuV, DhouibM, PoindronP. Nitric oxide synthase inhibition by haem oxygenase decreases macrophagenitric-oxide-dependent cytotoxicity: a negative feedback mechanism for the regulation of nitric oxide production. Res Immunol, 149:741–744. 1998.
454.
UmHS, KangEB, LeemYH, ChoIH, YangCH, ChaeKR, HwangDY, ChoJY. Exercise training acts as a therapeutic strategy for reduction of the pathogenic phenotypes for Alzheimer's disease in an NSE/APPsw-transgenic model. Int J Mol Med, 22:529–539. 2008.
455.
UmemuraK, KimuraH. Hydrogen sulfide enhances reducing activity in neurons: neurotrophic role of H2S in the brain?Antioxid Redox Signal, 9:2035–2041. 2007.
456.
VargasMR, JohnsonDA, SirkisDW, MessingA, JohnsonJA. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci, 28:13574–13581. 2008.
457.
VerkhratskyA. The endoplasmic reticulum and neuronal calcium signalling. Cell Calcium, 32:393–404. 2002.
VioliF, MarinoR, MiliteMT, LoffredoL. Nitric oxide and its role in lipid peroxidation. Diabetes Metab Res Rev, 15:283–288. 1999.
460.
WagnerF, AsfarP, CalziaE, RadermacherP, SzabóC. Bench-to-bedside review: Hydrogen sulfide—the third gaseous transmitter: applications for critical care. Crit Care, 13:213. 2009.
461.
WakabayashiN, Dinkova-KostovaAT, HoltzclawWD, KangMI, KobayashiA, YamamotoM, KenslerTW, TalalayP. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA, 101:2040–2045. 2004.
WattenbergLW. Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. J Natl Cancer Inst, 48:1425–1430. 1972.
464.
WattenbergLW, CocciaJB, LamLK. Inhibitory effects of phenolic compounds on benzo(a)pyrene-induced neoplasia. Cancer Res, 40:2820–2823. 1980.
465.
WelchH, PriceCW, RandallWA. Increase in fatality rate of E. Typhosa for white mice by streptomycin. J Am Pharm, 35:155–158. 1946.
466.
WesterheideSD, AnckarJ, StevensSM, SistonenLJr., MorimotoRI. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science323, 1063–1066. 2009.
467.
WesterheideSD, BosmanJD, MbadughaBN, KawaharaTL, MatsumotoG, KimS, GuW, DevlinJP, SilvermanRB, MorimotoRI. Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem, 279:56053–56060. 2004.
468.
WierinckxA, BrevéJ, MercierD, SchultzbergM, DrukarchB, Van DamAM. Detoxication enzyme inducers modify cytokine production in rat mixed glial cells. J Neuroimmunol, 166:132–143. 2005.
469.
YangF, LimGP, BegumAN, UbedaOJ, SimmonsMR, AmbegaokarSS, ChenPP, KayedR, GlabeCG, FrautschySA, ColeGM. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem, 280:5892–5901. 2005.
470.
YaoCJ, LinCW, Lin-ShiauSY. Roles of thapsigargin-sensitive Ca2+ stores in the survival of developing cultured neurons. J Neurochem, 73:457–465. 1999.
471.
YatesMS, TranQT, DolanPM, OsburnWO, ShinS, McCullochCC, SilkworthJB, TaguchiK, YamamotoM, WilliamsCR, LibyKT, SpornMB, SutterTR, KenslerTW. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid treated mice. Carcinogenesis, 30:1024–1031. 2009.
YoungLJ, CaugheyWS. Oxygenation of carbon monoxide by bovine heart cytochrome c oxidase. Biochemistry, 25:152–161. 1986.
474.
YuZ, LuoH, FuW, MattsonMP. The endoplasmic reticulum stress-responsive protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression of oxidative stress and stabilization of calcium homeostasis. Exp Neurol, 155:302–314. 1999.
475.
YuZF, MattsonMP. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J Neurosci Res, 57:830–839. 1999.
476.
YuZF, Nikolova-KarakashianM, ZhouD, ChengG, SchuchmanEH, MattsonMP. Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis. J Mol Neurosci, 15:85–97. 2000.
477.
ZhangDD, HanninkM. Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. Mol Cell Biol, 23:8137–8151. 2003.
478.
ZhangK, KaufmanRJ. Protein folding in the endoplasmic reticulum and the unfolded protein response. Handb Exp Pharmacol, 172:69–91. 2006.
479.
ZhangK, ZhaoT, HuangX, LiuZH, XiongL, LiMM, WuLY, ZhaoYQ, ZhuLL, FanM. Preinduction of HSP70 promotes hypoxic tolerance and facilitates acclimatization to acute hypobaric hypoxia in mouse brain. Cell Stress Chaperones, 14:407–415. 2009.
480.
ZhangY, TangL. Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacol Sin, 28:1343–1354. 2007.
481.
ZhangY, TalalayP, ChoCG, PosnerGH. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA, 89:2399–2403. 1992.
482.
ZhaoJ, KoboriN, AronowskiJ, DashPK. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett, 393:108–112. 2006.
ZhaoJ, MooreAN, RedellJB, DashPK. Enhancing expression of Nrf2-driven genes protects the blood brain barrier after brain injury. J Neurosci, 27:10240–10248. 2007.
485.
ZhaoX, SunG, ZhangJ, StrongR, DashPK, KanYW, GrottaJC, AronowskiJ. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke, 38:3280–3286. 2007.
486.
ZhouP, QianL, IadecolaC. Nitric oxide inhibits caspase activation and apoptotic morphology but does not rescue neuronal death. J Cereb Blood Flow Metab, 25:348–357. 2005.
487.
ZlotkinS. A new approach to control of anemia in “at risk” infants and children around the world. 2004 Ryley-Jeffs memorial lecture. Can J Diet Pract Res, 65:136–138. 2004.
